Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

Differences between clinical trial efficacy and real-world effectiveness.

Davidson MH.

Am J Manag Care. 2006 Nov;12(15 Suppl):S405-11. Review.

2.

Therapy to reduce risk of coronary heart disease.

Rader DJ.

Clin Cardiol. 2003 Jan;26(1):2-8. Review.

3.

Treatment of dyslipidaemia in high-risk patients: too little, too late.

Barter P.

Int J Clin Pract Suppl. 2002 Jul;(130):15-9. Review.

PMID:
12296602
4.

Statins: balancing benefits, efficacy and safety.

Clearfield MB.

Expert Opin Pharmacother. 2002 May;3(5):469-77. Review.

PMID:
11996626
5.

The human and economic costs of undertreatment with statins.

Durrington P.

Int J Clin Pract. 2002 Jun;56(5):357-68. Review.

PMID:
12137445
6.

Non-high-density lipoprotein cholesterol: the forgotten therapeutic target.

Maki KC, Galant R, Davidson MH.

Am J Cardiol. 2005 Nov 7;96(9A):59K-64K; discussion 34K-35K. Epub 2005 Oct 21. Review.

PMID:
16291016
7.

How do we achieve optimal cardiovascular risk reduction?

Gotto AM Jr.

Clin Cardiol. 2001 Aug;24(8 Suppl):III8-12. Review.

8.

Update on lipid-lowering therapy and LDL-cholesterol targets.

Wiviott SD, Cannon CP.

Nat Clin Pract Cardiovasc Med. 2006 Aug;3(8):424-36. Review.

PMID:
16874355
9.
10.

[A new approach to the treatment of dyslipidemia].

Kevelaitiene S, Slapikas R.

Medicina (Kaunas). 2008;44(5):407-13. Review. Lithuanian.

11.

Cholesterol lowering in diabetes. New evidence supports aggressive LDL-C targets.

Rosenson RS.

Postgrad Med. 2005 Apr;117(4):17-20, 23-7. Review.

PMID:
15842129
12.

Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes.

Abdel-Maksoud M, Sazonov V, Gutkin SW, Hokanson JE.

J Cardiovasc Pharmacol. 2008 Apr;51(4):331-51. doi: 10.1097/FJC.0b013e318165e2e7. Review.

PMID:
18427276
13.

Pathogenesis and management of diabetic dyslipidemia.

Izkhakov E, Meltzer E, Rubinstein A.

Treat Endocrinol. 2003;2(4):231-45. Review.

PMID:
15966559
14.
15.

Lipid-lowering interventions in managed care settings.

Fox J, Jones K.

Am J Med. 2001 Apr 16;110 Suppl 6A:24S-30S. Review.

PMID:
11311194
16.

Treatment of high-risk older persons with lipid-lowering drug therapy.

Aronow WS.

Am J Ther. 2008 Mar-Apr;15(2):102-7. doi: 10.1097/MJT.0b013e31802b5aa4. Review.

PMID:
18356628
17.

Dyslipidaemia in diabetic patients: time for a rethink.

Shepherd J.

Diabetes Obes Metab. 2007 Sep;9(5):609-16. Review.

PMID:
17697054
18.
19.
20.

Lipid lowering treatment patterns and goal attainment in Nordic patients with hyperlipidemia.

Svilaas A, Strandberg T, Eriksson M, Hildebrandt P, Westheim A.

Scand Cardiovasc J. 2008 Aug;42(4):279-87. doi: 10.1080/14017430802073073. Review.

PMID:
18609053

Supplemental Content

Support Center